1. Home
  2. EBS vs IMRX Comparison

EBS vs IMRX Comparison

Compare EBS & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.00

Market Cap

411.1M

Sector

Health Care

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$6.01

Market Cap

340.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBS
IMRX
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.1M
340.7M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
EBS
IMRX
Price
$8.00
$6.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$17.20
AVG Volume (30 Days)
638.8K
699.7K
Earning Date
04-30-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
125.83
37.75
EPS
0.93
N/A
Revenue
$742,900,000.00
N/A
Revenue This Year
$1.29
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.71
$1.10
52 Week High
$14.06
$10.08

Technical Indicators

Market Signals
Indicator
EBS
IMRX
Relative Strength Index (RSI) 43.26 61.71
Support Level $7.73 $6.00
Resistance Level $8.54 $7.67
Average True Range (ATR) 0.34 0.35
MACD 0.02 0.05
Stochastic Oscillator 21.09 79.81

Price Performance

Historical Comparison
EBS
IMRX

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: